줄기세포 치료 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 세포원별, 용도별, 최종사용자별, 지역별 부문, 경쟁(2020-2030년)

Global Stem Cell Therapy Market was valued at USD 368.54 Million in 2024 and is expected to reach USD 769.87 Million by 2030 with a CAGR of 13.06% during the forecast period. Stem cell therapy, also referred to as regenerative medicine, facilitates the repair response of diseased, dysfunctional, or injured tissue through the utilization of stem cells or their derivatives. It represents the subsequent phase in organ transplantation, substituting donor organs-which are limited in availability-with cells. Stem cells possess the capability to differentiate into various cell types within the human body, functioning as a restorative mechanism. There exist two primary classifications of stem cells: embryonic stem cells and adult stem cells. Stem cells are further categorized into two major groups: pluripotent and multipotent. Pluripotent stem cells, derived from embryos or fetal tissues, undergo replication and contribute to the development of cells and tissues within the mesoderm, ectoderm, and endoderm-the three primary germ layers. For instance, in January 2020, researchers from the University of Miami administered two stem cells infusions to COVID-19 patients that were suffering from lung damage. The results concluded that there were no significant side effects, and the therapy was reliable.

Key Market Drivers

Increasing Technological Advancement in Stem Cell Therapeutics

The progress of stem cell therapies has been facilitated by advancements in stem cell isolation, expansion, and differentiation techniques. Scientists are currently investigating different sources of stem cells, such as embryonic stem cells, induced pluripotent stem cells (iPSCs), and adult stem cells. Furthermore, emerging technologies like gene editing (e.g., CRISPR) hold promise for improving the precision and effectiveness of stem cell-based treatments. The constant awareness and availability of stem cell therapies have triggered an increasing demand for innovation and system development. Market players are actively seeking collaborations to enhance their research and development activities, aiming to expand the stem cell treatment market in both developing and developed nations. Substantial funding has been invested in cell-based research, particularly in the field of induced pluripotent stem cells. This technique involves genetic reprogramming of adult human stem cells to obtain embryonic-like stem cells, serving as a viable alternative in the market.

Key Market Challenges

High-Cost Treatment

Developing and implementing stem cell therapies involves significant research, clinical trials, and manufacturing costs. The high costs associated with research, development, and production can limit accessibility for patients. The expansion of the cell treatment market has been hindered by its high cost. As individuals seek out the latest therapeutic options, cell treatments have gained popularity as a treatment choice. Despite the significant increase in demand, cell treatments remain prohibitively expensive. Joint injections alone can cost up to $1,000, while more complex procedures may reach up to $100,000. In the United States, the average cost of stem cell therapy is projected to range between $4,000 and $8,000 per patient in 2020. Consequently, the growth of the stem cell therapy market is constrained by the elevated cost of treatment.

Key Market Trends

Increased Clinical Trials and Research

The field of stem cell therapy is likely to see continued growth in clinical trials and research studies. As scientists better understand stem cell behavior and optimize their use, more evidence will be generated to support their efficacy and safety for various medical conditions. Ongoing research will likely reveal new and diverse applications for stem cell therapy across various medical conditions. As the understanding of stem cells expands, scientists may identify previously unrecognized opportunities for treatment.

Key Market Players

• Biorestorative Therapies Inc.
• Celgene corporation
• ReNeuron Group plc
• Opexa Therapeutics, Inc.
• Pluristem Therapeutics Inc
• STEMCELL Technologies Inc.
• Biovault family
• Precious Cells International Ltd
• Mesoblast Ltd
• Seneca Biopharmaceuticals, Inc.

Report Scope:

In this report, the Global Stem Cell Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Stem Cell Therapy Market, By Type:

• Allogenic Transplants
• Autologous Transplants

Stem Cell Therapy Market, By Cell Source:

• Adipose Tissue-Derived Mesenchymal Stem Cells
• Bone Marrow-Derived Mesenchymal Stem Cells
• Cord Blood/Embryonic Stem Cells

Stem Cell Therapy Market, By Application:

• Cancer
• Musculoskeletal Disorder
• Wounds and Injuries
• Cardiovascular Disease
• Others

Stem Cell Therapy Market, By End User:

• Hospitals and Surgical Centres
• Therapeutic Companies

Stem Cell Therapy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Stem Cell Therapy Market.

Available Customizations:

Global Stem Cell Therapy market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Stem Cell Therapy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Allogenic Transplants, Autologous Transplants)
  • 5.2.2. By Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells)
  • 5.2.3. By Application (Cancer, Musculoskeletal Disorder, Wounds and Injuries, Cardiovascular Disease, Others)
  • 5.2.4. By End User (Hospitals and Surgical Centres, Therapeutic Companies)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Stem Cell Therapy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Cell Source
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Stem Cell Therapy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Cell Source
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Stem Cell Therapy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Cell Source
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Stem Cell Therapy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Cell Source
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Stem Cell Therapy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Cell Source
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Stem Cell Therapy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Cell Source
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Stem Cell Therapy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Cell Source
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Stem Cell Therapy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Cell Source
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. France Stem Cell Therapy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Cell Source
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Stem Cell Therapy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Cell Source
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Stem Cell Therapy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Cell Source
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Stem Cell Therapy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Cell Source
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Stem Cell Therapy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Cell Source
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Stem Cell Therapy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Cell Source
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Stem Cell Therapy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Cell Source
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Stem Cell Therapy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Cell Source
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Stem Cell Therapy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Cell Source
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Stem Cell Therapy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Cell Source
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Stem Cell Therapy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Cell Source
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Stem Cell Therapy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Cell Source
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Stem Cell Therapy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Cell Source
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Stem Cell Therapy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Cell Source
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Stem Cell Therapy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Cell Source
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Stem Cell Therapy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Cell Source
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

13. Global Stem Cell Therapy Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Biorestorative Therapies Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Celgene corporation
• 14.3. ReNeuron Group plc
• 14.4. Opexa Therapeutics, Inc.
• 14.5. Pluristem Therapeutics Inc
• 14.6. STEMCELL Technologies Inc.
• 14.7. Biovault family
• 14.8. Precious Cells International Ltd
• 14.9. Mesoblast Ltd
• 14.10. Seneca Biopharmaceuticals, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer